A Pivotal Study of Sensory Stimulation in Alzheimer's Disease (HOPE Study) (NCT05637801)
A Randomized, Double-blind, Sham-controlled Pivotal Study of Sensory Stimulation in Subjects With Alzheimer's Disease (HOPE Study)
π©Ί Plain-English Summary (8th-Grade Level)
This is a randomized, double-blind, sham-controlled pivotal study of sensory stimulation in subjects with mild to moderate AD. Up to approximately 670 subjects will be treated with either Active or Sham investigational device, Spectrisβ’ AD, for 60 minutes daily for approximately 12 months. Efficacy will be measured using the Integrated Alzheimer's Disease Mini-Mental State Exam (MMSE) Activities of Daily Living (ADCS-ADL) Rating Scale (iADMARS).
Who can join: Review the eligibility criteria below.
Location: CCT Research - Gilbert Neurology Partners β Gilbert, Arizona
Age range: 50 Years to 90 Years
π§ͺ Interventions in This Study
π "Do I Qualify?" β 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria β
π All Participating Trial Locations (68 Sites)
Showing the first 25 of 68 sites.
- CCT Research - Gilbert Neurology Partners β Gilbert, Arizona
- Barrow Neurological Institute β Phoenix, Arizona
- CCT Research - Foothills Research Center β Phoenix, Arizona
- Banner Sun Health Research Institute β Sun City, Arizona
- Advanced Research Center, Inc β Anaheim, California
- ATP Clinical Research, Inc. β Costa Mesa, California
- Neurology Center of North Orange County β Fullerton, California
- Syrentis Clinical Research β Santa Ana, California
- Office of Elizabeth Zarate-Rowell, MD β Seal Beach, California
- Mile High Research Center β Denver, Colorado
- JEM Research Institute β Atlantis, Florida
- Visionary Investigators Network- Aventura β Aventura, Florida
- South Lake Pain Institute β Clermont, Florida
- Arrow Clinical Trials β Daytona Beach, Florida
- Brain Matters Research β Delray Beach, Florida
- Neuropsychiatric Research Center of Southwest Florida β Fort Myers, Florida
- Alphab Global Research β Jupiter, Florida
- Charter Research - Lady Lake β Lady Lake, Florida
- Multi-Specialty Research Associates, Inc. β Lake City, Florida
- Premier Clinical Research Institute Inc. β Miami, Florida
- Visionary Investigators Network- Miami β Miami, Florida
- Aqualane Clinical Research β Naples, Florida
- Coastal Family Medicine - Orange Park β Orange Park, Florida
- K2 Medical Research - Orlando β Orlando, Florida
- Emerald Coast Neurology β Pensacola, Florida
π° Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA Β§ 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Alzheimer Disease
- The Use of Memantine for Prevention of Alzheimer's Disease β Charlottesville, Virginia
- Investigation of Inflammation Using [C-11]-CS1P1 β St Louis, Missouri
- Sleep Disturbance and Emotion Regulation Brain Dysfunction as Mechanisms of Neuropsychiatric Symptoms in Alzheimer's Dementia β Palo Alto, California
- High Frequency Light and Sound Stimulation to Improve Brain Functions in Alzheimer's Disease β Cambridge, Massachusetts
- A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease β Phoenix, Arizona
Explore by condition: All Alzheimer Disease clinical trials
π‘ How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.